Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 44.36% vs 26.58% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 26.48% vs 17.44% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -8.33% vs 152.27% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 24.73% vs 16.73% in Mar 2025
Compare Profit and Loss Results of Shelter Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
73.00
183.00
-110.00
-60.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
11.00
-11.00
-100.00%
Net Sales
73.00
171.00
-98.00
-57.31%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
55.00
123.00
-68.00
-55.28%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
9.00
-8.00
-88.89%
Operating Expenses
0.00
12.00
-12.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
6.00
-6.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
60.00
159.00
-99.00
-62.26%
Operating Profit (PBDIT) excl Other Income
12.00
12.00
0.00
0.00%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
12.00
17.00
-5.00
-29.41%
Interest
0.00
5.00
-5.00
-100.00%
Profit before Depriciation and Tax
12.00
11.00
1.00
9.09%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
12.00
5.00
7.00
140.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
12.00
5.00
7.00
140.00%
Provision for Tax
3.00
1.00
2.00
200.00%
Profit After Tax
9.00
3.00
6.00
200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
18.00
21.00
-3.00
-14.29%
Profit Available for appropriations
27.00
25.00
2.00
8.00%
Appropriations
27.00
25.00
2.00
8.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.57
2.3
4.27
185.65%
Profit And Loss - Net Sales
Net Sales 73.13 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 44.36% vs 26.58% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.48% vs 17.44% in Mar 2025
Profit And Loss - Interest
Interest 0.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.33% vs 152.27% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 9.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 24.73% vs 16.73% in Mar 2025